CE
Eberhardt, Christiane Sigrid
Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
---|---|---|---|---|---|---|---|
Rituximab‐to‐vaccine interval on SARS‐CoV‐2 immunogenicity in children : The potential role of prior natural infection | Pediatric allergy and immunology | 2024 | 38 | 12 | |||
Mise à jour des vaccins chez les personnes âgées | Revue médicale suisse | 2024 | 28 | 0 | |||
Influence of timing of maternal pertussis immunization on the avidity of transferred antibodies in term and preterm neonates | Clinical infectious diseases | 2023 | 27 | 12 | |||
Antibody response in children with multisystem inflammatory syndrome related to COVID-19 (MIS-C) compared to children with uncomplicated COVID-19 | Frontiers in immunology | 2023 | 141 | 18 | |||
High-throughput spatiotemporal monitoring of single-cell secretions via plasmonic microwell arrays | Nature biomedical engineering | 2023 | 71 | 77 | |||
COVID-19 Vaccine Development - where do we stand? | 2022 | 235 | 15 | ||||
Omicron-specific cytotoxic t-cell responses after a third dose of mrna covid-19 vaccine among patients with multiple sclerosis treated with ocrelizumab | JAMA neurology | 2022 | 175 | 99 | |||
Adjuvanted recombinant zoster vaccine in solid organ transplant and hematopoietic stem-cell transplant recipients | Current opinion in infectious diseases | 2022 | 36 | 111 | |||
Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years | Scientific reports | 2022 | 81 | 13 | |||
Gynécologie-obstétrique - Grossesse et Covid-19 : recommandations médicamenteuses et vaccinales en 2021 | Revue médicale suisse | 2022 | 50 | 21 | |||
A comparison of Sars-Cov-2 vaccine platforms : the CoviCompare project | Nature medicine | 2022 | 34 | 31 | |||
Transient elevation of humoral responses against apolipoprotein A-1 following COVID-19 and its association with symptoms persistence | 90th EAS (European Atherosclerosis Society) Congress | 2022 | 61 | 0 | |||
Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta | Nature | 2022 | 1,371 | 185 | |||
Robust T-Cell Responses in Anti-CD20 Treated Patients Following COVID-19 Vaccination: A Prospective Cohort Study | Clinical infectious diseases | 2022 | 154 | 27 | |||
Autoantibodies against apolipoprotein A-1 after COVID-19 predict symptoms persistence | European journal of clinical investigation | 2022 | 358 | 75 | |||
Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs | Nature communications | 2022 | 217 | 113 | |||
T cell receptor sequencing reveals reduced clonal breadth of T-cell responses against SARS-CoV-2 after natural infection and vaccination in allogeneic hematopoietic stem cell transplant recipients | Annals of oncology | 2022 | 123 | 39 | |||
Contrasting behavior between the three human monocyte subsets in dengue pathophysiology | iScience | 2022 | 51 | 14 | |||
Fitness of B-Cell Responses to SARS-CoV-2 WT and Variants Up to One Year After Mild COVID-19 – A Comprehensive Analysis | Frontiers in immunology | 2022 | 137 | 54 | |||
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation : An updated EASL position paper | Journal of hepatology | 2022 | 28 | 39 | |||
Is there a role for childhood vaccination against COVID-19? | Pediatric allergy and immunology | 2021 | 213 | 1 | |||
Maladies infectieuses | Revue médicale suisse | 2021 | 311 | 79 | |||
SARS-COV2- infection as a trigger of humoral response against apolipoprotein A-1 | EAS Congress 2021 | 2021 | 251 | 38 | |||
Defining HPV-specific B cell responses in patients with head and neck cancer | Nature | 2021 | 69 | 0 | |||
The Potential Role of Nonhuman Primate Models to Better Comprehend Early Life Immunity and Maternal Antibody Transfer | Vaccines | 2021 | 70 | 49 | |||
Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunity | Cell reports | 2021 | 332 | 164 | |||
Clinical, virological and immunological features of a mild case of SARS-CoV-2 re-infection | Clinical Microbiology and Infection | 2021 | 460 | 262 | |||
Vaccination against Cancer or Infectious Agents during Checkpoint Inhibitor Therapy | Vaccines | 2021 | 37 | 64 | |||
Longitudinal Analysis of Inflammatory Response to SARS-CoV-2 in the Upper Respiratory Tract Reveals an Association with Viral Load, Independent of Symptoms | Journal of clinical immunology | 2021 | 232 | 83 | |||
Antibody responses to SARS-CoV2 vaccination in allogeneic hematopoietic stem cell transplant recipients | Bone marrow transplantation | 2021 | 227 | 2 | |||
Influenza Immunization in the Context of Preexisting Immunity | Cold Spring Harbor perspectives in medicine | 2021 | 29 | 8 | |||
Coronavirus disease 2019 vaccination in transplant recipients | Current opinion in infectious diseases | 2021 | 69 | 0 | |||
Immunological assessment of pediatric multisystem inflammatory syndrome related to COVID-19 | Journal of the Pediatric Infectious Diseases Society | 2021 | 268 | 27 | |||
Paradoxes and Uncertainties of Immunomodulatory Treatments in the Fight Against Coronavirus Disease 2019 | Clinical infectious diseases | 2021 | 146 | 41 | |||
Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study | Clinical Microbiology and Infection | 2021 | 340 | 165 | |||
SARS-CoV-2 infection as a trigger of humoral response against apolipoprotein A-1 | European Journal of Clinical Investigation | 2021 | 306 | 206 | |||
Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity | Clinical microbiology and infection | 2021 | 645 | 0 | |||
Faudra-t-il vacciner les enfants contre le Covid-19 ? | Revue médicale suisse | 2021 | 54 | 21 | |||
EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients | Journal of hepatology | 2021 | 46 | 66 | |||
Functional HPV-specific PD-1+ stem-like CD8 T cells in head and neck cancer | Nature | 2021 | 71 | 0 | |||
Protected or not protected, that is the question - First data on COVID-19 vaccine responses in patients with NAFLD and liver transplant recipients | Journal of hepatology | 2021 | 77 | 46 | |||
Multi-stage group testing improves efficiency of large-scale COVID-19 screening | Journal of Clinical Virology | 2020 | 266 | 0 | |||
Persistence of varicella-zoster virus-specific plasma cells in adult human bone marrow following childhood vaccination | Journal of Virology | 2020 | 365 | 0 | |||
Challenges and issues of SARS-CoV-2 pool testing | The Lancet Infectious Diseases | 2020 | 278 | 4 | |||
Daily viral kinetics and innate and adaptive immune response assessment in COVID-19: a case series | mSphere | 2020 | 432 | 170 | |||
Maternal antibodies inhibit neonatal and infant responses to vaccination by shaping the early-life B cell repertoire within germinal centers | Cell Reports | 2019 | 242 | 145 | |||
Does Maternal Tdap Vaccination During Pregnancy Increase the Risk of Developing Chorioamnionitis? - A Monocentric, Retrospective, Observational Study | 2019 | 70 | 4 | ||||
Characterization of virus-specific immune response during varicella zoster virus encephalitis in a young adult | Clinical Infectious Diseases | 2019 | 257 | 0 | |||
Understanding the immunology of the Zostavax shingles vaccine | Current Opinion in Immunology | 2019 | 234 | 0 | |||
Overcoming the neonatal limitations of inducing germinal centers through liposome-based adjuvants including c-type lectin agonists trehalose dibehenate or curdlan | Frontiers in Immunology | 2018 | 429 | 399 | |||
Review of maternal immunisation during pregnancy: focus on pertussis and influenza | Swiss Medical Weekly | 2017 | 299 | 114 | |||
Pertussis Antibody Transfer to Preterm Neonates After Second- Versus Third-Trimester Maternal Immunization | Clinical Infectious Diseases | 2017 | 575 | 224 | |||
Antenatal vaccination to decrease pertussis in infants: safety, effectiveness, timing, and implementation | The Journal of Maternal - Fetal & Neonatal Medicine | 2017 | 420 | 0 | |||
Maternal immunization earlier in pregnancy maximizes antibody transfer and expected infant seropositivity against pertussis | Clinical infectious diseases | 2016 | 670 | 5 | |||
Recommandations de vaccination chez la femme enceinte : une piqûre de rappel | Revue médicale suisse | 2016 | 373 | 2 | |||
Reply to Abu Raya et al | Clinical infectious diseases | 2016 | 401 | 3 | |||
MF59 Mediates Its B Cell Adjuvanticity by Promoting T Follicular Helper Cells and Thus Germinal Center Responses in Adult and Early Life | The Journal of immunology | 2015 | 570 | 2 | |||
Needle-free and adjuvant-free epicutaneous boosting of pertussis immunity: Preclinical proof of concept | Vaccine | 2015 | 580 | 130 | |||
The Seatbelt Syndrome-Do We Have a Chance?: A Report of 3 Cases With Review of Literature | Pediatric emergency care | 2015 | 511 | 2 | |||
Cholestasis as the leading sign of a transmesenteric hernia in a split-liver transplanted child - a case report and review of literature | Pediatric transplantation | 2012 | 605 | 0 |